Both helper-dependent high-capacity Ad vectors that completely lack viral coding sequences or conditionally replicating Ads (also known as CRAds) driven by tumour-specific promoters in their E1A regions have been used to deliver TRAIL gene [24, 61, 65]. This evidence concerns the gene TNFSF10 and neoplasm.